Beclomethasone dipropionate , administered either via a double-strength ( 84 microg/puff ) or regular-strength ( 42 microg/puff ) inhaler dosed at 840 microg/day showed no evidence of hypothalamic-pituitary-adrenocortical axis suppression in adults with moderate asthma .
